CVE:ZMD

ZoomMed Stock Forecast, Price & News

C$0.02

+0.02 (+∞)

(As of 10/4/2018)

Add

Compare

Today's Range: C$0.02
▼
C$0.02
50-Day Range: C$0.02
▼
C$0.02
52-Week Range: C$0.01
▼
C$0.05

Volume: 220,000 shs
Average Volume: 290,486 shs
Market Capitalization: C$2.03 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

ZoomMed MarketRank™ Forecast

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: N/A
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

0.22 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for ZoomMed.

0.0 Short Interest

Short Interest
There is no current short interest data available for ZMD.

0.0 Dividend Strength

Dividend Yield
ZoomMed does not currently pay a dividend.
Dividend Growth
ZoomMed does not have a long track record of dividend growth.

0.0 Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for ZMD.

1.1 News and Social Media Coverage

News Sentiment
ZoomMed has a news sentiment score of 0.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Computer and Technology companies.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, ZoomMed insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of ZoomMed is -1.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of ZoomMed is -1.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

See Top Rated MarketRank™ Stocks Here

30 days | 90 days | 365 days | Advanced Chart

Receive ZMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ZoomMed and its competitors with MarketBeat's FREE daily newsletter.

About ZoomMed

ZoomMed Inc., together with its subsidiaries, develops and markets a range of computer applications designed for healthcare professionals primarily in the United States and the United Kingdom. The company builds and operates a clinical information exchange platform between physicians, pharmacists, and various other stakeholders of the healthcare sector, such as pharmacists, specialists, pharmaceutical companies, laboratories, physiotherapy clinics, and other organizations. It also offers ZRx Prescriber, a technological Web application that enables physicians to generate prescriptions. ZoomMed Inc. was incorporated in 2005 and is headquartered in Brossard, Canada.

ZMD Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Stock Exchange: CVE
Industry: Health Information Services
Sub-Industry: N/A
Sector: Computer and Technology
Current Symbol: CVE:ZMD
CUSIP: N/A
CIK: N/A
Web: zoommedcorpo.com
Phone: +1-450-6785457
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.01
Quick Ratio: 0.01

Sales & Book Value

Annual Sales: C$10,000.00
Price / Sales: 203.39
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: C($0.02) per share
Price / Book: -0.88

Miscellaneous

Outstanding Shares: 135,591,000
Free Float: N/A
Market Cap: C$2.03 million
Optionable: Not Optionable
Beta: N/A

ZoomMed Frequently Asked Questions

How has ZoomMed's stock performed in 2022?: ZoomMed's stock was trading at C$0.02 at the beginning of 2022. Since then, ZMD shares have increased by 0.0% and is now trading at C$0.02.
View the best growth stocks for 2022 here.
Who are ZoomMed's key executives?: ZoomMed's management team includes the following people:
Mr. Yves Marmet, Chairman, CEO & Pres
Ms. Marie-Helene Pinard, CFO, VP of Operations & Fin., Sec. and Director
Mr. André Marmet, VP of Corp. Bus.
Who are some of ZoomMed's key competitors?: Some companies that are related to ZoomMed include IQ-AI (IQAI), CardioComm Solutions (EKG), Sensyne Health (SENS), 1st Group (1ST), Alcidion Group (ALC), Artrya (AYA), Binovi Technologies (BNVIF), Cann American (CNNA), Carebook Technologies (CRBKF), Careteq (CTQ), CloudMD Software & Services (DOCRF), Cogstate (CGS), Corum Group (COO), Dialogue Health Technologies (CARE.TO) and EGF Theramed Health (EVAHF).
View all of ZMD's competitors.

What is ZoomMed's stock symbol?: ZoomMed trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ZMD."
How do I buy shares of ZoomMed?: Shares of ZMD and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.
What is ZoomMed's stock price today?: One share of ZMD stock can currently be purchased for approximately C$0.02.
How much money does ZoomMed make?: ZoomMed (CVE:ZMD) has a market capitalization of C$2.03 million and generates C$10,000.00 in revenue each year.
How can I contact ZoomMed?: ZoomMed's mailing address is 8005 du Quartier Blvd Suite 303, BROSSARD, QC J4Y 0N5, Canada. The official website for ZoomMed is zoommedcorpo.com. The company can be reached via phone at +1-450-6785457.

This page (CVE:ZMD) was last updated on 7/6/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources